Xanthines (Caffeine) and Nicotine

  • Marc A. Schuckit
Part of the Critical Issues in Psychiatry book series (CIPS)


This chapter deals with two of the most widely used legal drugs of abuse. Despite the relatively benign acute effects at low doses, the high prevalence of repeated and intense use results in frequent morbidity and (for tobacco) even a high level of mortality. Both of these substances are stimulantlike in their effects but are discussed here, rather than in chapter 5, because of their unique pharmacological mechanisms of action. The chapter deals first with the xanthines, including caffeine, and then goes on to a discussion of nicotine.


Smoking Cessation Major Depressive Disorder Withdrawal Symptom Nicotine Dependence Maternal Smoking 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Serafin, W. E. Drugs used in the treatment of asthma. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 659–682.Google Scholar
  2. 2.
    Greden, J. F., & Pomerleau, O. Caffeine-related disorders and nicotine-related disorders. In H. I. Kaplan & B. J. Saddock (Eds.), Comprehensive textbook of psychiatry (6th ed.). Baltimore, MD: Williams & Wilkins, 1995, pp. 799–810.Google Scholar
  3. 3.
    Greden, J. F., & Walters, A. Caffeine. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 294–307.Google Scholar
  4. 4.
    Migliardi, J. R., Armellino, J. J., Friedman, M., et al. Caffeine as an analgesic adjuvant in tension headache. Clinical Pharmacology & Therapeutics 56:576–586, 1994.Google Scholar
  5. 5.
    Winger, G., Hofmann, F. G., & Woods, J. H. A handbook on drug and alcohol abuse (3rd ed.). New York: Oxford University Press, 1992, pp. 142–149.Google Scholar
  6. 6.
    Kaplan, G. B., Greenblatt, D. J., Kent, M. A., et al. Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy. Neuropsychopharmacology 6:145–153, 1992.PubMedGoogle Scholar
  7. 7.
    Orlikov, A., & Ryzov, I. Caffeine-induced anxiety and increase of kynurenine concentration in plasma of healthy subjects: A pilot study. Biological Psychiatry 29:391–396, 1991.PubMedGoogle Scholar
  8. 8.
    Nehlig, A. Are we dependent upon coffee and caffeine? A review on human and animal data. Neuroscience and Biobehavioral Reviews 23:563–576, 1999.PubMedGoogle Scholar
  9. 9.
    Virus, R. M., Ticho, S., Pilditch, M., & Radulovacki, M. A comparison of the effects of caffeine 8-cyclo-pentyltheophylline, and alloxazine on sleep in rats. Neuropsychopharmacology 3:243–249, 1990.PubMedGoogle Scholar
  10. 10.
    Liguori, A., & Hughes, J. R. Caffeine self-administered in humans: 2. A within-subjects comparison of coffee and cola vehicles. Experimental and Clinical Psychopharmacology 5:295–303, 1997.PubMedGoogle Scholar
  11. 11.
    Bak, A. A. A., & Grobbee, D. E. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. New England Journal of Medicine 321:1423–1437, 1989.Google Scholar
  12. 12.
    Hughes, J. R., & Oliveto, A. H. A systematic survey of caffeine intake in Vermont. Experimental and Clinical Psychopharmacology 5:393–398, 1997.PubMedGoogle Scholar
  13. 13.
    Donnerstein, R. L., Zhu, D., Samson, R., et al. Acute effects of caffeine ingestion on signal-averaged electrocardiograms. American Heart Journal 136:643–646, 1998.PubMedGoogle Scholar
  14. 14.
    Mehta, A., Jain, A. C., Mehta, M. C., & Billie, M. Caffeine and cardiac arrhythmias. An experimental study in dogs with review of literature. Acta Cardiologica 52:273–283, 1997.PubMedGoogle Scholar
  15. 15.
    Sawynok, J. Pharmacological rationale for the clinical use of caffeine. Drugs 49:37–50, 1995.PubMedGoogle Scholar
  16. 16.
    Carrillo, J. A., Herraiz, A. G., Ramos, S. I., & Benítez, J. Effects of caffeine withdrawal from the diet on the metabolosm of clozapine in schizophrenic patients. Journal of Clinical Psychopharmacology 18:311–316, 1998.PubMedGoogle Scholar
  17. 17.
    Schuckit, M. A. A clinical review of interactions among medications. Developmental Disabilities: Clinical Insights 11, San Diego Regional Center for the Developmentally Disabled, 1999.Google Scholar
  18. 18.
    Schuckit, M. A. Are there useful amethystic agents? Vista Hill Foundation Drug Abuse & Alcoholism Newsletter, 23(1), 1994.Google Scholar
  19. 19.
    American Psychiatric Association. The diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press, 1994.Google Scholar
  20. 20.
    Schuckit, M. A. Educating yourself about alcohol and drugs. New York: Plenum Publishing Co., 1998.Google Scholar
  21. 21.
    Dager, S. R., Layton, M. E., Strauss, W., et al. Human brain metabolic response to caffeine and the effects of tolerance. American Journal of Psychiatry 156:229–237, 1999.PubMedGoogle Scholar
  22. 22.
    Lane, J. D. Effects of brief caffeinated-beverage deprivation on mood, symptoms, and psychomotor performance. Pharmacology, Biochemistry and behavior 58:203–208, 1997.Google Scholar
  23. 23.
    Evans, S. M., & Griffiths, R. R. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. Journal of Pharmacology and Experimental Therapeutics 289:285–294, 1999.PubMedGoogle Scholar
  24. 24.
    Griffiths, R. R., & Mumford, G. K. Caffeine: A drug of abuse? In F. E. Bloo & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress. New York: Raven Press, 1995.Google Scholar
  25. 25.
    Hughes, J. R. Caffeine withdrawal, dependence and abuse. In T. A. Widiger et al. (Eds.), DSM-IV Sourcebook, Vol 1. Washington, DC: American Psychiatric Press, 1994.Google Scholar
  26. 26.
    Hughes, J. R. Treating smokers with current or past alcohol dependence. American Journal of Health behavior 20:286–290, 1996.Google Scholar
  27. 27.
    Ligouri, A., Hughes, J. R., & Oliveto, A. H. Caffeine self-administered in Humans: 1. Efficacy of cola vehicle. Experimental and Clinical Psychopharmacology 5:286–294, 1997.Google Scholar
  28. 28.
    Hughes, J. R. McHugh, P., & Holtzman, S. Caffeine and schizophrenia. Psychiatric Services 49:1415–1417, 1998.PubMedGoogle Scholar
  29. 29.
    Schuckit, M. A. Anxiety disorders and substance abuse. In A. Tasman & M. Riba (Eds.), Review of psychiatry, Vol. III. Washington, DC: American Psychiatric Press, 1992, pp. 403–417.Google Scholar
  30. 30.
    Swan, G. E., Carmelli, D., & Cardon, L. R. Heavy consumption of cigarettes, alcohol, and coffee in male twins. Journal of Studies on Alcohol 58:182–190, 1997.PubMedGoogle Scholar
  31. 31.
    Kendler, K. S., & Prescott, C. A. Caffeine intake, tolerance, and withdrawal in women: A population-based twin study. American Journal of Psychiatry 156:223–228, 1999.PubMedGoogle Scholar
  32. 32.
    Bauer, A. R., Rank, R. K., & Kerr, R. The effects of prolonged coffee intake on genetically identical mice. Life Sciences 21:63–70, 1977.PubMedGoogle Scholar
  33. 33.
    Hughes, J. R., & Hale, K. L. Behavioral effects of caffeine and other methylxanthines on children. Experimental and Clinical Psychopharmacology 5:87–95, 1998.Google Scholar
  34. 34.
    Zaslove, M. O., Beal, M., & McKinney, R. E. Changes in behaviors of inpatients after a ban on the sale of caffeinated drinks. Hospital and Community Psychiatry 42:84–85, 1991.PubMedGoogle Scholar
  35. 35.
    Mikkelsen, E. J. Caffeine and schizophrenia. Journal of Clinical Psychiatry 39:732–736, 1978.PubMedGoogle Scholar
  36. 36.
    Bruce, M., Scott, N., Shine, R., & Lader, M. Anxiogenic effects of caffeine in patients with anxiety disorders. Archives of General Psychiatry 49:867–869, 1992.PubMedGoogle Scholar
  37. 37.
    Goodwin, D. W., & Guze, S. B. Psychiatric diagnosis (5th ed.). New York: Oxford University Press, 1996.Google Scholar
  38. 38.
    Breier, A., Charney, D. S., & Heinger, G. R. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness. Archives of General Psychiatry 43:1029–1036, 1986.PubMedGoogle Scholar
  39. 39.
    Bhattacharya, S. K., Satyan, K. S., & Chakrabarti, A. Anxiogenic action of caffeine: an experimental study in rats. Jourmal of Psychopharmacology 11:219–224, 1997.Google Scholar
  40. 40.
    Lane, J. D., Phillips-Bute, B. G., & Pieper, C. F. Caffeine raises blood pressure at work. Psychosomatic Medicine 60:327–330, 1998.PubMedGoogle Scholar
  41. 41.
    LaCroix, A. Z., Mead, L. A., Liang, K. Y., et al. Coffee consumption and the incidence of coronary heart disease. New England Journal of Medicine 315:977–982, 1986.PubMedGoogle Scholar
  42. 42.
    Pehl, C., Pfeiffer, A., Wendl, B., & Kaess, H. The effect of decaffeination of coffee on gastro-oesophageal reflux in patients with reflux disease. Alimentary Pharmacology and Therapeutics 11:483–486, 1997.PubMedGoogle Scholar
  43. 43.
    Kelly, T. L., Mitler, M. M., & Bonnet, M. H. Sleep latency measures of caffeine effects during sleep deprivation. Electroencephalography and Clinical Neurophysiology 102:397–400, 1997.PubMedGoogle Scholar
  44. 44.
    Slattery, M. L., Caan, B. J., Anderson, K. E., & Potter, J. D. Intake of fluids and methylxanthine-containing beverages: association with colon cancer. International Journal of Cancer 81:199–204, 1999.Google Scholar
  45. 45.
    Eskenazi, B., Stapleton, A. L., Kharrazi, M., & Chee, W. Y. Associations between maternal decaffeinated and caffeinated coffee consumption and fetal growth and gestational duration. Epidemiology 10:242–249, 1999.PubMedGoogle Scholar
  46. 46.
    Taylor, P. Agents acting at the neuromuscular junction and autonomic ganglia. In R. W. Ruddon & A. G. Gilman (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995.Google Scholar
  47. 47.
    Janiger, O., & deRios, M. D. Suggestive hallucinogenic properties of tobacco. Medical Anthropology Newsletter 4:1–6, 1973.Google Scholar
  48. 48.
    Hughes, J. R., Fiester, S., Goldstein, M., et al. Practice guidelines for the treatment of patients with nicotine. American Journal of Psychiatry 153 (supp):1–29, 1996.Google Scholar
  49. 49.
    Schelling, T. C. Addictive drugs: The cigarette experience. Science 255:430–433, 1992.PubMedGoogle Scholar
  50. 50.
    Kendler, K. S., Neale, M. C., Sullivan, P., et al. A population-based twin study in women of smoking initiation and nicotine dependence. Psychological Medicine 29:299–308, 1999.PubMedGoogle Scholar
  51. 51.
    Schmitz, J. M., Schneider, N. G., & Jarvik, M. E. Nicotine. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 276–294.Google Scholar
  52. 52.
    Boomsma, D. I., Koopmans, J. R., Van Doornen, L. J. P., & Orlebeke, J. F. Genetic and social influences on starting to smoke: A study of Dutch adolescent twins and their parents. Addiction 89:219–226, 1994.PubMedGoogle Scholar
  53. 53.
    True, W. R., Heath, A. C., Scherrer, J. F., Waterman, B., Goldberg, J., Lin, N., Eisen, S. A., Lyons, M. J., & Tsuang, M. T. Genetic and environmental contributions to smoking. Addiction 92:1277–1287, 1997.PubMedGoogle Scholar
  54. 54.
    Borland, R., Cappiello, M., & Owen, N. Leaving work to smoke. Addiction 92:1361–1368, 1997.PubMedGoogle Scholar
  55. 55.
    Single, E., Robson, L., Xie, X., & Rehm, J. The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction 95:991–1006, 1998.Google Scholar
  56. 56.
    O’Brien, C. Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 557–577.Google Scholar
  57. 57.
    Hatsukami, D., Nelson, R., & Jensen, J. Smokeless tobacco: Current status and future directions. British Journal of Addiction 86:559–563, 1991.PubMedGoogle Scholar
  58. 58.
    Glover, E. D., Sachs, D. P. L., Stitzer, M. L., et al. Smoking cessation in highly dependent smokers with 4 mg nicotine polacrilex. American Journal of Health behavior 20:319–332, 1996.Google Scholar
  59. 59.
    Caraballo, R. S., Giovino, G. A., Pechacek, T. F., et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers. Journal of the American Medical Association 280:135–139, 1998.PubMedGoogle Scholar
  60. 60.
    Perez-Stable, E., Herrera, B., Jacob, P., III, & Benowitz, N. L. Nicotine metabolism and intake in black and white smokers. Journal of the American Medical Association 280:152–156, 1998.PubMedGoogle Scholar
  61. 61.
    Corrigall, W. A. Understanding brain mechanisms in nicotine reinforcement. British Journal of Addiction 86:507–510, 1991.PubMedGoogle Scholar
  62. 62.
    Hughes, J. R., Stead, L. F., & Lancaster, T. R. Anxiolytics and antidepressants in smoking cessation. In T. Lancaster, C. Silagy, & D. Fullerton (Eds.), Tobacco addiction module of the Cochrane database of systematic reviews. Oxford: The Cochrane Collaboration, 1997.Google Scholar
  63. 63.
    Glassman, A. H., & Koob, G. F. Psychoactive smoke. Nature 379:677–678, 1996.PubMedGoogle Scholar
  64. 64.
    Krishnan-Sarin, S., Rosen, M. I., & O’Malley, S. S. Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. Archives of General Psychiatry 56:663–668, 1999.PubMedGoogle Scholar
  65. 65.
    Wewers, M. E., Dhatt, R., & Tejwani, G. A. Naltrexone administration effects ad libitum smoking behavior. Psychopharmacology 140:185–190, 1998.PubMedGoogle Scholar
  66. 66.
    Pianezza, M. L., Sellers, E. M., & Tyndale, R. F. Nicotine metabolism defect reduces smoking. Nature 393: 750, 1998.PubMedGoogle Scholar
  67. 67.
    Messina, E. S., Tyndale, R. F., & Sellers, E. M. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. Pharmacology and Experimental Therapeutics 282:1608–1614, 1997.Google Scholar
  68. 68.
    Phillips, A. N., Wannamethee, S. G., Walker, M., et al. Life expectancy in men who have never smoked and those who have smoked continuously: 15-year follow-up of large cohort of middle aged British men. British Medical Journal 313:907–908, 1996.PubMedGoogle Scholar
  69. 69.
    Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Household Survey on drug abuse: Population estimates 1997. Rockville, MD: U.S. Department of Health and Human Services, 1998.Google Scholar
  70. 70.
    Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use from the Monitoring the Future Study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.Google Scholar
  71. 71.
    Pohl, R., Yeragani, V. K., Balon, R., et al. Smoking in patients with panic disorder. Psychiatric Research 43:253–262, 1992.Google Scholar
  72. 72.
    Collins, A. C. Genetic influences on tobacco use: A review of human and animal studies. International Journal of Addictions 25:35–55, 1991.Google Scholar
  73. 73.
    Carmelli, D., Swan, G. E., Robinette, D., & Fabsitz, R. Genetic influences on smoking—A study of male twins. New England Journal of Medicine 327:829–833, 1992.PubMedGoogle Scholar
  74. 74.
    Patton, G. C., Carlin, J. B., Coffey, C., et al. The course of early smoking: A population-based cohort study over three years. Addiction 93:1251–1260. 1998.PubMedGoogle Scholar
  75. 75.
    Russell, M. A. H. The nicotine addiction trap: A 40-year sentence for four cigarettes. British Journal of Addiction 85:293–300, 1990.PubMedGoogle Scholar
  76. 76.
    McNeill, A. D. The development of dependence on smoking in children. British Journal of Addiction 86:589–592, 1991.PubMedGoogle Scholar
  77. 77.
    Breslau, N., Kibey, M., & Andreski, P. Nicotine dependence, major depression, and anxiety in young adults. Archives of General Psychiatry 48:1069–1074, 1991.PubMedGoogle Scholar
  78. 78.
    Pomerleau, O. F., Pomerleau, C. S., & Namenek, R. J. Early experiences with tobacco among women smokers, ex-smokers, and never-smokers. Addiction 93:595–599, 1998.PubMedGoogle Scholar
  79. 79.
    Severson, H. H., Eakin, E. G., Lichtenstein, E., & Stevens, V. J. The inside scoop on the stuff called snuff: An interview study of 94 adult male smokeless tobacco users. Journal of Substance Abuse 2:77–85, 1990.PubMedGoogle Scholar
  80. 80.
    Stuyt, E. B. Recovery rates after treatment for alcohol/drug dependence: Tobacco users vs. non-tobacco users. American Journal on Addictions 6:159–167, 1997.PubMedGoogle Scholar
  81. 81.
    Daeppen, J.-B., Smith, T. L., Danko, G. P., et al. Clinical correlates of cigarette smoking and nicotine dependence in alcohol dependent men and women. Submitted to Alcohol and Alcoholism.Google Scholar
  82. 82.
    West, R., & Hajek, P. What happens to anxiety levels on giving up smoking? American Journal of Psychiatry 154:1589–1592, 1997.PubMedGoogle Scholar
  83. 83.
    Hughes, J. R. Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology 60:689–697, 1992.PubMedGoogle Scholar
  84. 84.
    Hughes, J. R., Gust, S. W., Skoog, K., et al. Symptoms of tobacco withdrawal. Archives of General Psychiatry 48:52–59, 1991.PubMedGoogle Scholar
  85. 85.
    Williamson, D. F., Madans, J., Anda, R. F., et al. Smoking cessation and severity of weight gain in a national cohort. New England Journal of Medicine 324:739–745, 1991.PubMedGoogle Scholar
  86. 86.
    Leischow, S. J., & Stitzer, M. L. Smoking cessation and weight gain. British Journal of Addiction 86:577–581, 1991.PubMedGoogle Scholar
  87. 87.
    Covey, L. S., Glassman, A. H., & Stetner, F. Major depression following smoking cessation. American Journal of Psychiatry 154:263–265, 1997.PubMedGoogle Scholar
  88. 88.
    Schneider, N. G., Olmstead, R., Vaghaiwalla Mody, F., Doan, K., Franzon, M., Jarvik, M. E., & Steinberg, C. Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction 90:1671–1682, 1995.PubMedGoogle Scholar
  89. 89.
    Goldstein, M. G. Bupropion sustained release and smoking cessation. Journal of Clinical Psychiatry 4:66–72, 1998.Google Scholar
  90. 90.
    Jasinski, D. R., Sullivan, J. T., Testa, M., & Preston, K. Reduction of tobacco withdrawal symptoms by transcranial electrostimulation therapy (TCET). Paper presented at the CPDD Annual Scientific Meeting, Palm Beach, Florida, June 16–20, 1991.Google Scholar
  91. 91.
    Ashenden, R., Silagy, C. A., Lodge, M., & Fowler, G. A meta-analysis of the effectiveness of acupuncture in smoking cessation. Drug and Alcohol Review 16:33–40, 1997.PubMedGoogle Scholar
  92. 92.
    Addington, J., el-Guebaly, N., Campbell, W., et al. Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry 155:974–976, 1998.PubMedGoogle Scholar
  93. 93.
    Dalack, G. W., Becks, L., Hill, E., et al. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21:195–202, 1999.PubMedGoogle Scholar
  94. 94.
    Goff, D. C., Henderson, D. C., & Amico, E. Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. American Journal of Psychiatry 149:1189–1194, 1992.PubMedGoogle Scholar
  95. 95.
    Glassman, A. H. Cigarette smoking: Implications for psychiatric illness. American Journal of Psychiatry 150:546–553, 1993.PubMedGoogle Scholar
  96. 96.
    Breslau, N., Kilbey, M., & Andreski, R Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults. American Journal of Psychiatry 149:464–469, 1992.PubMedGoogle Scholar
  97. 97.
    Fowler, J. S., Volkow, N. D., Wang, G.-J., et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733–736, 1996.PubMedGoogle Scholar
  98. 98.
    Kendler, K. S., Neale, M. C., MacLean, C. J., et al. Smoking and major depression. Archives of General Psychiatry 50:36–43, 1993.PubMedGoogle Scholar
  99. 99.
    Fielding, J. E. Smoking: Health effects and control. New England Journal of Medicine 313:491–498, 1985.PubMedGoogle Scholar
  100. 100.
    Jarvik, M. E. Beneficial effects of nicotine. British Journal of Addiction 86:571–575, 1991.PubMedGoogle Scholar
  101. 101.
    Howard, G., Wagenknecht, L. E., Burke, G. L., et al. Cigarette smoking and progression of atherosclerosis: The atherosclerosis risk in communities (ARIC) study. Journal of the American Medical Association 279:119–124, 1998.PubMedGoogle Scholar
  102. 102.
    Palmer, J. R., Rosenberg, L., & Shapiro, S. “Low yield” cigarettes and the risk of nonfatal myocardial infarction in women. New England Journal of Medicine 320:1569–1573, 1989.PubMedGoogle Scholar
  103. 103.
    Rosenberg, L., Palmer, J. R., & Shapiro, S. Decline in the risk of myocardial infarction among women who stop smoking. New England Journal of Medicine 322:213–217, 1990.PubMedGoogle Scholar
  104. 104.
    Caro, C. G., Parker, K. H., Lever, M. J., & Fish, P. J. Effect of cigarette smoking on the pattern of arterial blood flow: Possible insight into mechanisms underlying the development of arteriosclerosis. Lancet 2:11–14, 1987.PubMedGoogle Scholar
  105. 105.
    Brennan, P. A., Grekin, E. R., & Mednick, S. A. Maternal smoking during pregnancy and adult male criminal outcomes. Archives of General Psychiatry 56:215–219, 1999.PubMedGoogle Scholar
  106. 106.
    Wakschlag, L. S., Lahey, B. B., Loeber, R., et al. Maternal smoking during pregnancy and the risk of conduct disorder in boys. Archives of General Psychiatry 54:670–676, 1997.PubMedGoogle Scholar
  107. 107.
    Räsänen, P., Hakko, H., Isohanni, M., et al. Maternal smoking during pregnancy and risk of criminal behavior among adult male offspring in the Northern Finland 1966 birth cohort. American Journal of Psychiatry 156:857–862, 1999.PubMedGoogle Scholar
  108. 108.
    Fergusson, D. M., Woodward, L. J., & Horwood, L. J. Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Archives of General Psychiatry 55:721–727, 1998.PubMedGoogle Scholar
  109. 109.
    Evans, H. J., Fletcher, J., Torrence, M., & Hargreave, T. B. Sperm abnormalities and cigarette smoking. Lancet 1:627–629, 1981.PubMedGoogle Scholar
  110. 110.
    Gold, D. R., Wang, X., Wypij, D., et al. Effects of cigarette smoking on lung function in adolescent boys and girls. New England Journal of Medicine 335:931–937, 1996.PubMedGoogle Scholar
  111. 111.
    Boyko, E. J. Risk of ulcerative colitis among cigarette smokers. New England Journal of Medicine 316:707–710, 1987.PubMedGoogle Scholar
  112. 112.
    Michnovicz, J. J., Hershcopf, R. J., Naganuma, H., et al. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New England Journal of Medicine 315:1305–1309, 1986.PubMedGoogle Scholar
  113. 113.
    Jensen, J., Christiansen, C., & Rodbro, P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. New England Journal of Medicine 313:973–975, 1985.PubMedGoogle Scholar
  114. 114.
    Steenland, K. Passive smoking and the risk of heart disease. Journal of the American Medical Association 267:94–99, 1992.PubMedGoogle Scholar
  115. 115.
    Cruickshanks, K. J., Klein, R., Klein, B. E. K., Wiley, T. L., Nondahl, D. M., & Tweed, T. S. Cigarette smoking and hearing loss. Journal of the American Medical Association 279:1715–1719, 1998.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Marc A. Schuckit
    • 1
  1. 1.University of California Medical School and Veterans Affairs San Diego Healthcare SystemSan DiegoUSA

Personalised recommendations